Qianjiang Yongan Pharmaceutical Management
Management criteria checks 2/4
Qianjiang Yongan Pharmaceutical's CEO is Rengui Hong, appointed in Jun 2021, has a tenure of 3.25 years. directly owns 0.061% of the company’s shares, worth CN¥1.30M. The average tenure of the management team and the board of directors is 8.6 years and 3.3 years respectively.
Key information
Rengui Hong
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.3yrs |
| CEO ownership | 0.06% |
| Management average tenure | 8.6yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
CEO
Rengui Hong (41 yo)
3.3yrs
Tenure
Mr. Rengui Hong is Managing Director and Director of Qianjiang Yongan Pharmaceutical Co. Ltd. from June 28, 2021.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Head of the Audit Department | 8yrs | CN¥633.80k | 0.061% CN¥ 1.3m | |
| Deputy General Manager | 18.5yrs | CN¥1.90m | 0.37% CN¥ 7.8m | |
| Deputy General Manager | 9.3yrs | CN¥1.16m | 0.096% CN¥ 2.0m | |
| Senior Management | 5.6yrs | CN¥931.40k | 0.017% CN¥ 356.8k | |
| MD & Director | 3.3yrs | no data | 0.061% CN¥ 1.3m | |
| Deputy General Manager | 11.2yrs | CN¥1.62m | 0.096% CN¥ 2.0m |
8.6yrs
Average Tenure
53.5yo
Average Age
Experienced Management: 002365's management team is seasoned and experienced (8.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 3.3yrs | no data | 0.061% CN¥ 1.3m | |
| Chairman | 18.5yrs | CN¥3.76m | 21.67% CN¥ 457.6m | |
| Chairman of the Supervisory Board | 3.3yrs | CN¥166.70k | 0.19% CN¥ 4.0m | |
| Independent Director | 3.3yrs | CN¥80.00k | no data | |
| Independent Director | 3.3yrs | CN¥40.00k | no data | |
| Supervisor | 9.3yrs | no data | no data | |
| Non-Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data |
3.3yrs
Average Tenure
46yo
Average Age
Experienced Board: 002365's board of directors are considered experienced (3.3 years average tenure).